scispace - formally typeset
K

Kunio Itoh

Researcher at Tohoku Pharmaceutical University

Publications -  24
Citations -  341

Kunio Itoh is an academic researcher from Tohoku Pharmaceutical University. The author has contributed to research in topics: Aldehyde oxidase & Enzyme. The author has an hindex of 14, co-authored 24 publications receiving 326 citations.

Papers
More filters
Journal ArticleDOI

Stereoselective pharmacokinetics of RS‐8359, a selective and reversible MAO‐A inhibitor, by species‐dependent drug‐metabolizing enzymes

TL;DR: The rapid disappearance of the (S)-enantiomer from the plasma was thought to be due to the rapid metabolism of the (+/-)-4-cyanoanilino)-5,6-dihydro-7-hydroxy-7H-cyclopenta[d]pyrimidine by different drug-metabolizing enzymes, depending on species.
Journal ArticleDOI

Species differences in enantioselective 2-oxidations of RS-8359, a selective and reversible MAO-A inhibitor, and cinchona alkaloids by aldehyde oxidase.

TL;DR: In vitro results were in good accordance with previously reported in vivo excretion data of the 2‐keto metabolite and the non‐detectable plasma concentrations of the (S)‐enantiomer in monkeys and humans after administration of racemic RS‐8359.
Journal ArticleDOI

Lack of dimer formation ability in rat strains with low aldehyde oxidase activity

TL;DR: It is suggested that rat strains with low AO activity lack the ability to produce a dimer necessary for catalytic activity, and AO differences in rat strains should be discussed in terms of the expression levels of the dimer itself.
Journal ArticleDOI

Cloning, expression, and characterization of male cynomolgus monkey liver aldehyde oxidase

TL;DR: The results suggested that two forms of aldehyde oxidase in monkey were the expression products by a single gene, and the biphasic pattern was observed for Eadie-Hofstee plots of the (S)-enantiospecific 2-oxidation activity of RS-8359 with the expressed and cytosolic monkey liver alde Hyde oxidase.
Journal ArticleDOI

Stereospecific oxidation of the (S)-enantiomer of RS-8359, a selective and reversible monoamine oxidase A (MAO-A) inhibitor, by aldehyde oxidase.

TL;DR: The results suggest that the enzyme responsible for the biotransformation of RS-8359 to give the 2-keto derivative is aldehyde oxidase (EC 1.2.3.1).